QT Vascular unit granted Singapore patent for catheter

CATALIST-LISTED QT Vascular's wholly-owned US subsidiary TriReme Medical LLC has been granted a Singapore patent for its "balloon catheter with improved column strength and torque", which is used in the group's GliderXtreme PTA balloon catheter.

The GliderXtreme PTA balloon catheter already has regulatory clearance in Japan and China. Along with the Glider PTCA balloon catheter, sales of GliderXtreme PTA in Asia are expected to add to the company's growth in the region in 2015, said QT Vascular on Wednesday.

Dr Eitan Konstantino, the group's chief executive officer, commented: "This is another notch in the belt for the group, as we continue to achieve key milestones and deliver on our internal targets. Singapore is the home base of the group and we are delighted to obtain this patent here.

"We are committed to driving value for our shareholders through innovative solutions that improve patients' lives and drive down healthcare costs. This patent, together with previously granted patents in Japan and China, is another step in building global value."